CSL362 potently and specifically depletes pDCs in vitro and ablates SLE-immune complex-induced IFN responses
2023 · iScience · 14 citations
https://doi.org/10.1016/j.isci.2023.107173
S
Shereen Oon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
1.0K
Citations
19
h-index
29
i10-index
Shereen Oon is an academic researcher from Queensland University of Technology. The author has contributed to research in topics: Systemic Lupus Erythematosus Research & Monoclonal and Polyclonal Antibodies Research & Atherosclerosis and Cardiovascular Diseases. The author has an h-index of 19, co-authored 85 publications.
ORCID: 0000-0002-6822-5711Papers by this author
worksAcute copper toxicity following copper glycinate injection
2006 · Internal Medicine Journal · 13 citations
https://doi.org/10.1111/j.1445-5994.2006.01195.x
Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus
2025 · Lupus Science & Medicine · 7 citations
https://doi.org/10.1136/lupus-2024-001363
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study
2024 · Advances in Rheumatology · 5 citations
https://doi.org/10.1186/s42358-024-00366-y
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort
2025 · Arthritis Research & Therapy · 2 citations
https://doi.org/10.1186/s13075-025-03622-8
POS1160 CLINICAL CHARACTERISTICS AND RESPONSE TO STANDARD-OF-CARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH OR WITHOUT ANTI-RIBONUCLEOPROTEIN (RNP) ANTIBODIES
2024 · Annals of the Rheumatic Diseases · 0 citations
https://doi.org/10.1136/annrheumdis-2024-eular.2745
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat